The UFC released a statement Tuesday on its official website updating the status of superstar Brock Lesnar‘s in-competition drug test:
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar that his in-competition sample collection from July 9, 2016, at UFC 200, has tested positive for the same substance as his previously announced out-of-competition collection on June 28, 2016.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed at UFC 200 in Las Vegas.
Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.
The USADA has not released any information pertaining to the substance allegedly found in Lesnar’s system in both tests.
More to follow.
You can follow Timothy Rapp on Twitter.
Read more MMA news on BleacherReport.com